ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,462,000 | +283.3% | 465,564 | +674.7% | 0.00% | +200.0% |
| Q4 2021 | $1,686,000 | -28.9% | 60,098 | -13.9% | 0.00% | 0.0% |
| Q3 2021 | $2,372,000 | -18.8% | 69,785 | -2.4% | 0.00% | -50.0% |
| Q2 2021 | $2,920,000 | -14.1% | 71,471 | -15.4% | 0.00% | 0.0% |
| Q1 2021 | $3,400,000 | -51.6% | 84,459 | -28.9% | 0.00% | -50.0% |
| Q4 2020 | $7,019,000 | +68.9% | 118,708 | +38.9% | 0.00% | +33.3% |
| Q3 2020 | $4,155,000 | +32.4% | 85,439 | +31.7% | 0.00% | +50.0% |
| Q2 2020 | $3,139,000 | +93.9% | 64,888 | +11.4% | 0.00% | +100.0% |
| Q1 2020 | $1,619,000 | +40.3% | 58,268 | +51.1% | 0.00% | 0.0% |
| Q4 2019 | $1,154,000 | +53.9% | 38,575 | +58.9% | 0.00% | 0.0% |
| Q3 2019 | $750,000 | – | 24,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |